General Cannabis Corp. (CANN) is Growing and Expanding with the Cannabis Market


General Cannabis is Growing and Expanding with the Cannabis Market, Analyst Review

Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on General Cannabis Corp. (CANN), a company focused on providing lease growing space and similar facilities to accredited marijuana operating companies.

General Cannabis is a Denver-based company and offers a variety of products and services to companies in the sector. Its integrated solutions range from operational and compliance to security, marketing, and financing needs. The company operates through a number of subsidiaries including Chiefton Supply, Next Big Corp, Iron Protection all of which have stakes in the multi-billion cannabis industry.

In the past 52 weeks, shares of CANN have traded as low as $1.08 and as high as $11.19

Get an analyst review and target price and company 2018 trends and outlook READ MORE

Copy and paste to your browser may be required to view the report –

On April 20, 2018 the company announced the closing of a private placement transaction with various private parties including existing and new investors in General Cannabis. The Company issued $5.54 million of senior secured promissory notes and an aggregate of 4,432,000 warrants to purchase common stock at the closing. The notes bear interest at 8.5% per annum and are secured by all of the Company’s assets. The warrants have an exercise price of $2.35 per share. The proceeds of this debt raise will be used primarily to fund the Company’s expansion and for working capital.

Read about CANN 2017 milestones and get a FYE 2017 financial review READ MORE

Copy and paste to your browser may be required to view the report –


Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


Please enter your comment!
Please enter your name here